{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 33,
        "end": 49
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 86,
        "end": 108
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 114,
        "end": 138
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 141,
        "end": 144
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 169,
        "end": 174
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 194,
        "end": 203
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 86,
        "end": 146
      }
    },
    {
      "id": "T12",
      "obj": "Disease",
      "span": {
        "begin": 23,
        "end": 27
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "16940443_5",
  "text": "RESULTS : Treatment of BAFs with prostaglandin E2 or a surrogate hormonal cocktail of dibutyryl ( Bt2 ) cAMP plus phorbol 12, 13-diacetate ( PDA ) significantly reduced BRCA1 levels and induced aromatase mRNA levels ."
}
